State Institute for Drug Control

24. 05. 2022

Scientific Advice on Marketing Authorisation Issues

Upon request, the Marketing Authorisation Section of the State Institute for Drug Control (hereinafter referred to as the “Institute”) provides Scientific Advice concerning...

23. 05. 2022

REG-94 version 2

29. 04. 2022

Opinion of SUKL´s Department of Clinical Trials of Medicinal Products from the 22 November 202 will expire on the 23 May 2022.

29. 04. 2022

List of reimbursed medicinal products valid as of 1.5.2022

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...

13. 04. 2022

UST-29 version 22

06. 04. 2022

PHV-6 version 3

06. 04. 2022

PHV-4 version 8

31. 03. 2022

List of reimbursed medicinal products valid as of 1.4.2022

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...